Thin film wound dressing

Information

  • Patent Grant
  • 9017302
  • Patent Number
    9,017,302
  • Date Filed
    Friday, August 26, 2011
    13 years ago
  • Date Issued
    Tuesday, April 28, 2015
    9 years ago
Abstract
A composite wound dressing and delivery apparatus includes a substantially transparent dressing layer having a lower surface that is coated with a pressure sensitive for applying the dressing layer over a wound to define a reservoir in which a negative pressure may be maintained. A substantially transparent backing layer adhered to the lower surface of the dressing layer in a releasable manner, and a vacuum port is centrally located on the dressing layer. The vacuum port is adapted to provide fluid communication between a vacuum source and the reservoir through the dressing layer. A targeting grid associated with either the dressing layer or the backing layer includes regularly spaced reference marks along at least two axes extending from the vacuum port.
Description
BACKGROUND

1. Technical Field


The present disclosure relates generally wound dressings, and in particular to a delivery apparatus for the application of thin film dressings over a wound for use in a treatment such as negative wound pressure therapy.


2. Background of Related Art


Wound dressings are generally placed over a wound to protect and promote healing of the wound. One type of wound dressing consists essentially of a thin membrane of a polymer or similar material, coated on an underside with a pressure-sensitive adhesive. The adhesive may adhere the dressing to healthy skin surrounding the wound such that the dressing provides an effective bacterial barrier to protect the wound from contamination. Because of their extremely elastic nature, thin polymeric film dressings may readily conform to irregular contours of a patient's skin while promoting patient movement and comfort. This type of dressing may also be sufficiently transparent to permit visual inspection of the wound without the need for removing the dressing and exposing the wound to contaminants in the environment.


One technique that may utilize a thin film dressing may be described as negative wound pressure therapy (NWPT). The thin film dressing may be positioned to form a substantially fluid tight seal with the skin surrounding the wound to define a reservoir over the wound where a negative pressure may be maintained. The reservoir subjects the wound to a sub-atmospheric pressure to effectively draw wound fluid, including liquid exudates, from the wound with, e.g., a vacuum pump. Vacuum pressure may be applied continuously, or in varying intervals, depending on the nature and severity of the wound. This technique has been found to promote blood flow to the wound area, stimulate the formation of granulation tissue and encourage the migration of healthy tissue over the wound. This type of treatment may subject a thin film dressing to repeated changes of size and shape, taking advantage of the flexibility of the dressing.


The flexibility of a thin film dressing may, however, present difficulties in the application of the dressing to a wound site. For example, the dressing may tend to fold, wrinkle and adhere to itself. To mitigate these tendencies, a delivery layer may be supplied with the dressing to temporarily support the dressing until the dressing is applied. When a thin film dressing is applied as part of an NWPT treatment, additional concerns arise including properly sizing the dressing and appropriately locating a vacuum port relative to the wound. Accordingly, a need exists for a composite dressing and delivery apparatus suitable for use in conjunction with an NWPT treatment.


SUMMARY

A composite wound dressing and delivery apparatus includes a substantially transparent dressing layer having a lower surface that is coated with a pressure sensitive for applying the dressing layer over a wound to define a reservoir in which a negative pressure may be maintained. A substantially transparent backing layer adhered to the lower surface of the dressing layer in a releasable manner, and a vacuum port is centrally located on the dressing layer. The vacuum port is adapted to provide fluid communication between a vacuum source and the reservoir through the dressing layer. A targeting grid associated with either the dressing layer or the backing layer includes regularly spaced reference marks along at least two axes extending from the vacuum port.


The targeting grid may be applied to the backing layer, and may include rule marks associated with two orthogonal axes extending from the vacuum port such that the targeting grid is arranged for Cartesian measurement of a distance to the vacuum port. At least a portion of the rule marks may be associated with numerical markers corresponding to units of a standard measurement system, and the numerical markers may identify a number of the units that is twice a distance from a center of the vacuum port.


The targeting grid may include orthogonal gridlines, including major gridlines and minor gridlines where the major gridlines are adapted to appear more prominent than the minor gridlines. The targeting grid may alternatively include curvilinear rule lines arranged around the vacuum port such the targeting grid is arranged for radial measurement of a distance to the vacuum port.


The apparatus may also include a substantially transparent delivery layer adhered to the upper surface of the dressing layer in a releasable manner. The backing layer may include a first identifier prominently visible thereon and the delivery layer may include a second identifier obscured by the backing layer such that the second identifier is revealed by the removal of the backing layer. The first and second identifiers may thus indicate an order in which the backing layer and delivery layer should be removed from the dressing layer.


The delivery layer may include a slit extending between a central opening and an exterior edge of the delivery layer to permit the delivery layer to be removed from the dressing layer when a vacuum tube is coupled to the vacuum port. The delivery layer may comprise a pair of opposed tabs protruding beyond the extents of the dressing layer. The apparatus also include a dressing layer that is generally triangular in shape.


According to another aspect of the disclosure, a composite wound dressing and delivery apparatus includes a substantially transparent dressing layer having a lower surface and an upper surface. The lower surface is coated with a pressure sensitive adhesive such that the dressing layer may form a fluid tight seal over a wound to define a reservoir in which a negative pressure may be maintained. The apparatus also includes substantially transparent backing layer adhered to the lower surface of the dressing layer in a releasable manner, and a substantially transparent delivery layer adhered to the upper surface of the dressing layer in a releasable manner. A vacuum port is centrally located on the dressing layer, and is adapted to provide fluid communication between a vacuum source and the reservoir through the dressing layer. A targeting grid is associated with the dressing layer, backing layer or the delivery layer, and includes regularly spaced reference marks along at least two axes extending from the vacuum port. Numerical markers correspond to units of a standard measurement system, and identify a number of the units that is twice the distance from a center of the vacuum port.


According to another aspect of the disclosure, a negative wound pressure therapy kit includes a composite wound dressing, a delivery apparatus and a patch. The composite apparatus includes a dressing layer configured for placement over a wound to define a reservoir over the wound in which a negative pressure may be maintained, a backing layer adhered to the dressing layer in a releasable manner and a vacuum port for providing fluid communication through the dressing layer. The vacuum port exhibits a predetermined geometry. The patch includes a patch layer and a backing layer. The patch layer has an opening therein that exhibits a geometry substantially similar to the geometry of the vacuum port.


The kit may further include a filler material adapted for placement within a wound to capture wound exudates, a wound contact layer adapted for placement adjacent the wound to promote unidirectional flow of wound exudates, or a canister adapted for placement exterior to the wound for the collection of wound exudates.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the present disclosure and, together with the detailed description of the embodiments given below, serve to explain the principles of the disclosure.



FIG. 1 is a cross sectional view of a thin film wound dressing as applied in an NWPT treatment apparatus;



FIG. 2 is an exploded perspective view of a composite dressing and delivery apparatus for the thin film wound dressing of FIG. 1 including a dressing layer, a backing layer and a delivery layer;



FIG. 3 is a flow diagram describing a process for changing the dressing of FIG. 1;



FIGS. 4A through 6B are top plan views of alternate embodiments of a composite dressing and delivery apparatus (designated “A”), and corresponding views of the dressing layers prepared for application with backing layers removed (designated “B”);



FIGS. 7A through 9B are top plan views of patches for use with a thin film dressing as supplied (designated “A”), and corresponding views of the patches prepared for application with backing layers removed (designated “B”);



FIG. 10A is a perspective view of a thin film dressing as applied in an NWPT treatment;



FIGS. 10B and 10C are top plan views of the thin film dressing of FIG. 10A as supplied (designated “B”) and as prepared for application (designated “C”);



FIG. 11A is a perspective view of a thin film dressing as applied in an NWPT treatment;



FIGS. 11B and 11C are top plan views of the thin film dressing of FIG. 11A as supplied (designated “B”) and as prepared for application (designated “C”);



FIG. 12A is a perspective view of a thin film dressing as applied in an NWPT treatment; and



FIGS. 12B and 11C are top plan views of the thin film dressing of FIG. 11A as supplied (designated “B”) and as prepared for application (designated “C”).





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

Referring initially to FIG. 1, a conventional NWPT apparatus is depicted generally as 10 for use on a wound “w” surrounded by healthy skin “s.” The NWPT apparatus 10 includes a wound dressing 12 positioned relative to the wound “w” to define a reservoir 14 in which a negative pressure appropriate to stimulate healing may be maintained.


Wound dressing 12 includes a contact layer 18 positioned in direct contact with the bed of wound “w” and may be formed from perforated film material. An appropriate perforated material permits the negative pressure applied to the reservoir to penetrate into the wound “w,” and also permits exudates to be drawn through the contact layer 18. Passage of wound fluid through the contact layer 18 is preferably unidirectional such that exudates do not flow back into the wound bed. Unidirectional flow may be encouraged by conical or directional apertures formed in the contact layer 18, or a lamination of materials having absorption properties differing from those of contact layer 18. A non-adherent material may be selected such that contact layer 18 does not tend to cling to the wound “w” or surrounding tissue when it is removed. One exemplary material that may be used as a contact layer 18 is sold under the trademark XEROFORM® and VENTEX® by Tyco Healthcare Group LP (d/b/a Covidien)


Wound filler 20 is positioned in the wound “w” over the contact layer 18 and is intended to allow wound dressing 12 to absorb, capture and/or wick wound exudates. Wound filler 20 is cut to a shape that is conformable to the shape of wound “w,” and may be packed up to the level of healthy skin “s,” or alternatively, wound filler 20 may overfill the wound “w.” An absorbent material such as non-woven gauze, reticulated foam, or alginate fibers may be used for filler 20 to transfer any exudate that migrates through contact layer 18 away from the wound “w”. An antimicrobial dressing sold under the trademark KERLIX®AMD by Tyco Healthcare Group LP (d/b/a Covidien), may be suitable for use as filler 20.


Wound dressing 12 also includes a cover layer 24. Cover layer 24 may be positioned over the wound “w” to form a substantially fluid-tight seal with the surrounding skin “s.” Thus, cover layer 24 may act as both a microbial barrier to prevent contaminants from entering the wound “w,” and also a fluid barrier maintaining the integrity of vacuum reservoir 14. Cover layer 24 is preferably formed from a moisture vapor permeable membrane to promote the exchange of oxygen and moisture between the wound “w” and the atmosphere, and is preferably transparent permit a visual assessment of wound conditions without requiring removal of the cover layer 24. A membrane that provides a sufficient moisture vapor transmission rate (MVTR) is a transparent membrane sold under the trade name POLYSKIN®II by Tyco Healthcare Group LP (d/b/a Covidien) Cover layer 24 may be customized from a composite dressing and delivery apparatus 100 (FIG. 2) as described in greater detail below.


A vacuum port 30 having a flange 34 may also be included in wound dressing 12 to facilitate connection of the wound dressing 12 to fluid conduit 36. The vacuum port 30 may be configured as a rigid or flexible, low-profile component, and may be adapted to receive a fluid conduit 36 in a releasable and fluid-tight manner. An adhesive on the underside of flange 34 may provide a mechanism for affixing the vacuum port 30 to the dressing 12, or alternatively the flange 34 may be positioned within reservoir 14 (not shown) such that an adhesive on an upper side of the flange 34 affixes the vacuum port 30. However it is affixed to the dressing, a hollow interior of the vacuum port 30 provides fluid communication between the fluid conduit 36 and the reservoir 14. Vacuum port 30 may assume various other forms discussed below.


Fluid conduit 36 extends from the vacuum port 30 to provide fluid communication between the reservoir 14 and collection canister 40. Any suitable conduit may be used for fluid conduit 36 including those fabricated from flexible elastomeric or polymeric materials. Fluid conduit 36 may connect components of the NWPT apparatus by conventional air-tight means such as friction fit, bayonet coupling, or barbed connectors. The conduit connections may be made permanent, or alternatively a quick-disconnect or other releasable means may be used to provide some adjustment flexibility to the apparatus 10.


Collection canister 40 may comprise any container suitable for containing wound fluids. For example, a rigid bottle may be used as shown or alternatively a flexible polymeric pouch may be appropriate. Collection canister 40 may contain an absorbent material to consolidate or contain the wound drainage or debris. For example, super absorbent polymers (SAP), silica gel, sodium polyacrylate, potassium polyacrylamide or related compounds may be provided within canister 40. At least a portion of canister 40 may be transparent to assist in evaluating the color, quality or quantity of wound exudates. A transparent canister may thus assist in determining the remaining capacity of the canister or when the canister should be replaced.


Leading from collection canister 40 is another section of fluid conduit 36 providing fluid communication with vacuum source 50. Vacuum source 50 generates or otherwise provides a negative pressure to the NWPT apparatus 10. Vacuum source 50 may comprise a peristaltic pump, a diaphragmatic pump or other mechanism that is biocompatible and draws fluids, e.g. atmospheric gasses and wound exudates, from the reservoir 14 appropriate to stimulate healing of the wound “w.” Preferably, the vacuum source 50 is adapted to produce a sub-atmospheric pressure in the reservoir 14 ranging between about 20 mmHg and about 500 mm Hg, about 75 mm Hg to about 125 mm Hg, or, more preferably, between about 40 mm HG and 80 mm Hg. Referring now to FIG. 2, a composite wound dressing and delivery apparatus 100 includes three distinct layers. Centrally located is the dressing layer 102 that may be used to form cover layer 34. Dressing layer 102 is interposed between a backing layer 104 and a delivery layer 106. Each of the three distinct layers 102, 104, and 106 is generally transparent to facilitate placement of the dressing layer 102 over a wound.


Dressing layer 102 may be formed from a variety of thin, transparent, polymeric membranes, such as polyurethane, elastomeric polyester or polyethylene. The thickness of the dressing layer 102 may, for example, be in the range of about 0.8 mils to about 1.2 mils. Thicknesses in this range may permit dressing layer 102 to conform to the contours of a patient's skin surrounding a wound, and accommodate evacuation cycles associated with an NWPT procedure. While the dressing layer 102 may be manufactured in any desired size or shape, the particular geometry of the wound to be treated may prompt customization of each individual dressing layer 102. As provided, dressing layer 102 is generally rectangular having a length of about 6 inches and a width of about 4 inches.


Dressing layer 102 has a lower surface 108 and an upper surface 110. Lower surface 108 is coated with an adhesive to facilitate adherence of the dressing layer 102 to the healthy skin “s” surrounding the wound “w.” The adhesive coating should provide firm, continuous adhesion to the skin “s” such that leak paths are not readily formed between the dressing layer 102 and the skin “s” when as reservoir 14 is subjected to the evacuation cycles of an NWPT treatment. The adhesive should also not unduly interfere with the transparency of dressing layer 102, and should peel away from the skin easily when the dressing layer 102 is no longer required.


The adhesive coating also preferably does not interfere with the transmission of moisture vapor through dressing layer 102. To promote enhanced moisture vapor transmission rate (MVTR) of the dressing layer 102, the adhesive coating may be interrupted in some embodiments such that only a periphery of dressing layer 102 is coated to form a seal with the skin “s” leaving a central portion of the dressing layer 102 uncoated. This arrangement is not necessarily preferred since cover layer 102 may be customized to accommodate the particular geometry of an individual wound and an appropriate periphery may not be known at the time of manufacturing. An adhesive coated substantially over the entire lower surface 108 may be selected that exhibits an MVTR equal to that of the film material.


Centrally located on the dressing layer 102 is a vacuum port 112 to facilitate connection to a vacuum tube 38. Vacuum port 112 is depicted schematically and may assume a variety of forms. For example, a structure similar to vacuum port 30 having a flange pre-affixed to dressing layer 102 may be provided along with the composite dressing 100. Alternatively, the vacuum port 112 may consist essentially of a pre-cut hole in the dressing layer 102, or in other embodiments, vacuum port 112 may comprise a marking to indicate a central location of the dressing layer 102 in which an opening may be cut by a clinician after dressing layer 102 is applied over a wound “w.”


Backing layer 104 is generally transparent and has a firm but releasable affinity for the adhesively coated lower surface 108 of dressing layer 102. Backing layer 104 covers the lower surface 104 and includes a peripheral region 114 that extends substantially beyond at least one edge of the dressing layer 102. Peripheral region 114 thus provides a gripping surface to facilitate the separation of the backing layer 112 from the dressing layer 102. Peripheral region 114 includes an indicator, such as first numerical indicator 116, printed or otherwise applied thereto. First numerical indicator 116 provides a prominent visual queue to indicate the order in which the three distinct layers 102, 104 and 106 should be separated.


Opposite peripheral region 114, backing layer 104 includes a background region 118 upon which a solid stripe is printed. Background region 118 is less translucent than dressing layer 102 and may be substantially opaque. Also printed on backing layer 104 is a circular reference 122, which is centrally located as to correspond with the location of vacuum port 112 on dressing layer 102. Surrounding the circular reference 122, a targeting grid 126 is printed or otherwise applied with regularly spaced reference lines in two orthogonal directions. Targeting grid 126 may be used to facilitate placement of the vacuum port 108 centrally over a wound “w” by providing a reference for measurement of the wound “w,” and by providing a reference for precise cutting or customization of the dressing layer 102.


Delivery layer 106 is adhered to the upper surface 110 of the dressing layer 102 in a releasable manner. Delivery layer 106 is substantially rigid in relation to dressing layer 102 to maintain the dressing layer 102 in a relatively smooth and unwrinkled configuration while the dressing layer 102 is applied to the skin “s.” Delivery layer 106 is, however, sufficiently flexible to conform to irregular contours of the skin “s” such that the dressing layer 102 may be pressed onto the skin “s” to form a substantially fluid tight seal therewith.


Preferably, both delivery layer 106 and upper surface 110 are non-adhesive, and may be adhered by heat lamination contact or similar means. A peripheral region 130 of delivery layer 106 overlies dressing layer 102, but is not adhered to dressing layer 102. Peripheral region 130 thus provides a gripping surface to facilitate separation of the delivery layer 106 from the dressing layer 102.


An indicator such as second numerical indicator 132 is positioned on the peripheral region 130 to indicate the order in which the three distinct layers 102, 104 and 106 should be separated. Second numerical indicator 132 is defined by the transparent or relatively transparent text and graphics surrounded by a darker background area of peripheral region 130. The background area of peripheral region 130 may be printed to have an appearance that is substantially similar to the appearance of background region 118 on backing layer 104. In this way, second numerical indicator 132 may be camouflaged or obscured when the backing layer 104 is adhered to the dressing layer 102 and revealed when backing layer 104 is separated from the dressing layer 102.


Delivery layer 106 also includes a central opening 134 to accommodate vacuum port 112 on the dressing layer 102 and a printed boundary 136 opposite peripheral region 130. Printed boundary 136 may be coincident with an edge of the dressing layer 102 to help identify the edge when the delivery layer 106 is adhered to the dressing layer 102.


Referring now to FIG. 3, a process is described for changing a dressing 12 of an NWPT apparatus 10, as depicted in FIG. 1. The process makes use of a composite dressing and delivery apparatus 100 as depicted in FIG. 2, or any of the alternative composite apparatuses discussed below. The procedure includes four major steps, each including a number of sub-steps. Each of the steps and sub-steps may be performed in any suitable order including the order depicted.


In the first major step, the wound “w” is prepared. The vacuum source 50 may be deactivated and the existing dressing 12 may be removed. The wound “w” may be cleaned and wound conditions may then be assessed. The sub-step of documenting the wound conditions may be performed concurrently with the second major step of preparing the dressing, and may be facilitated by any of the composite wound dressing and delivery apparatuses depicted in FIG. 4A through FIG. 6B.



FIG. 4A depicts a composite wound dressing and delivery apparatus 200 having a Cartesian targeting grid 204 printed on a backing layer 206 thereof to assist in documentation of wound conditions. Cartesian targeting grid 204 includes a horizontal axis 208 and an orthogonal vertical axis 210 extending through a central location corresponding with the location of vacuum port 212. Rule marks 216 flank the horizontal and vertical axes 208, 210 in a regularly spaced intervals preferably corresponding to the units of a standard measurement system, e.g. metric or English. Numerical markers 218 may correspond to a number of inches that is twice the distance from a center of vacuum port 212. Composite wound dressing and delivery apparatus 200 may be placed over a wound “w” such that vacuum port 212 is centrally located, and a distance across the wound along in two axes may be noted and documented.



FIG. 5A and FIG. 6A depict alternate composite dressing and delivery apparatuses 300, 400, which may be used in a similar manner to document the size of a wound “w.” Composite apparatus 300 includes a targeting grid 304 similar to targeting grid 126 discussed above with reference to FIG. 2. Targeting grid 304 includes major gridlines 306 which are adapted to appear more prominent than minor gridlines 308. Each of the grid lines 306, 308 may correspond to a predetermined unit of measurement and distance from vacuum port 312. Composite system 400 includes a polar or radial targeting grid 404. Radial targeting grid 404 includes curvilinear rule lines 406 arranged around vacuum port 412.


In the second major step, the dressing is prepared. Once supplies have been gathered, an NWPT package (not shown) may be opened. An NWPT package may be provided that includes a sterilized kit including various items used in an NWPT procedure such as a composite wound dressing and delivery apparatus 100, material for wound contact layer 18, material for filler 20 and other items including those described herein below. Once the NWPT package is opened, the packaging material may be used as a clean preparation surface for inventory and organization of the kit components. The packaging material should therefore exhibit a tendency to lie flat and should be sufficient in size to accommodate each of the kit components thereon.


Material may be provided in an NWPT kit for filler 20. The material may be cut to size to allow filler 20 to fill or overfill the wound “w” as described above. The composite system 100 may then be cut appropriate the size of the wound “w.” To allow dressing layer 102 to form an appropriate seal with the skin “s,” composite system 100 should be cut to permit from about one inch to about one and one half inches of contact between the skin “s” and the adhesively coated lower surface 108 of dressing layer 102 around the wound “w.” Cutting the composite system 100 may be facilitated by the targeting grid 126, which provides reference to guide the cut.


Surgical scissors (not shown), may be used to make the cut and may be sterilized or cleaned prior to each use. The scissors need not be included in the NWPT kit. The scissors may also be used to cut wound contact layer 18 to size before it is placed adjacent to the wound “w.”


In the third major step, the dressing may be applied to the wound “w.” The filler 20 may be placed over the contact layer 18. Often, a portion dressing layer 102 that was cut from composite system 100 in a previous step is used to tack the filler 20 in place.


Next, dressing layer 102 may be applied over the wound “w.” The backing layer 104 is first separated to expose the adhesive coating on the lower surface 108 of dressing layer 102. First numerical indicator 116 indicates that the peripheral region 114 may first be grasped to remove the backing layer 104. Once the adhesive is exposed, dressing layer 102 may be pressed onto the skin “s” to form a fluid-tight seal therewith. With backing layer 104 removed, second numerical indicator 132 is revealed as described above. The alternate embodiments depicted in FIGS. 4B, 5B and 6B demonstrate other arrangements that may permit a second numerical indicator to be revealed upon the removal of the respective backing layer. Second numerical indicator 132 indicates that the delivery layer 106 may be separated from dressing layer 102 once the dressing layer 102 has been placed over the wound “w.” The delivery layer 106 should readily separate from the upper surface 110 of the dressing layer 102 such that the seal formed around the wound “w” is not disturbed and so as not to cause the patient any undue pain.


If necessary, a hole may be cut in vacuum port 112 to receive fluid conduit 36. Fluid conduit 36 may be placed relative to vacuum port 112 such that the fluid conduit 36 may communicate with reservoir 14. Next, an exposed portion of fluid conduit may be oriented or routed so as not to interfere with patient movement or comfort. Again, a portion of the dressing layer 102 that was cut from composite system 100 in a previous step may be used to secure the fluid conduit 36.


In the fourth major step, treatment of the wound “w” may begin. The fluid conduit 36 may be connected to vacuum source 50 through canister 40. The vacuum source 99 may then be activated to evacuate atmospheric gasses from the reservoir 14. A distinctive sound or audible indicator may indicate whether a proper seal has been achieved over the wound “w.” If necessary, any leaks identified may be patched with a portion of the dressing layer 102 that was cut from composite system 100 in a previous step.


Alternatively, a prefabricated patch, such as the patches depicted in FIG. 7A through FIG. 9B, may be used to patch any leaks identified. Each of the patches depicted may be formed from materials similar to those selected for dressing layer 102, and may be provided with a composite delivery apparatus similar to the delivery apparatus provided for dressing layer 102. For example, a patch layer 502, as depicted in FIGS. 7A and 7B, includes a backing layer 504 and a delivery layer 506. Backing layer 504 includes a peripheral region 514 extending beyond an edge of the patch 502. First numerical indicator 516 indicates that peripheral region 514 may be grasped to remove the backing layer 504 and expose an adhesive coating on an underside of patch 502. A second numerical indicator 532 (FIG. 7B) is also thereby revealed. The patch layer 502 may be applied over a leak, and delivery layer 506 may be removed.


Patch layer 502 is shaped such that an opening or interior region 538 has a geometry that is substantially similar to the geometry of the vacuum port 112. Interior region 538 may be open to receive vacuum port 112 therein. Creating a seal around vacuum port 112 may present a challenge, and incorporating a patch layer 502 configured to approximate the particular size and shape of the perimeter of vacuum port 112 into an NWPT kit may be helpful. Opening 538 is substantially circular to accommodate vacuum port 112, but other configurations may be used. For example, a patch (not shown) having a semicircular or other arc shape may be provided.


Patch 542 depicted in FIGS. 8A and 8B has a substantially round geometry and may be provided to patch small leaks in anywhere on the dressing layer 102. Patch 562 depicted in FIGS. 9A and 9B has an elongate geometry and may be provided to patch a leak along an edge of dressing layer 102.


Each of the patches described above may be provided as a kit component in an NWPT package. Having prefabricated patches on hand can ensure the integrity of a fluid tight seal over a wound “w.” Also prefabricated patches may be used to tack filler 20 in place in a sterile manner, or to conveniently secure the position of fluid conduit 38. Prefabricated patches may be provided to serve any function that may otherwise be served by a portion of the dressing layer 102 that was cut from composite system 100.


A final sub-step may be to collect and retain any unused components, e.g., patches or portions of dressing layer 102, and to dispose of any refuse. Backing layer 104 and delivery layer 106 each include printing thereon, e.g., the targeting grid 126 or numerical identifiers 116, 132, which can assist in locating these components for disposal.


Referring now to FIG. 10A through FIG. 10C, an alternate embodiment of a composite dressing and delivery apparatus is depicted generally as 600. Composite system 600 includes a dressing layer 602, a backing layer 604 and a delivery layer 606. Delivery layer 606 includes a narrow slit 608 therein extending from central opening 610 to an exterior edge to allow the delivery layer 606 to be conveniently removed after fluid conduit 36 has been routed as depicted in FIG. 6A.


Backing layer 604 includes a peripheral region 614 with a first numerical indicator 616, and a background region 618 positioned along an edge orthogonal to the peripheral region 614. Delivery layer 606 includes a second numerical indicator 632 printed in a darker color than background region 618. Second numerical indicator 632 is thus visible when backing layer 604 is adhered to dressing layer 602, but more prominent when backing layer 604 is removed.


Referring now to FIG. 11A through FIG. 11C, an alternate embodiment of a composite dressing and delivery apparatus is depicted generally as 700. Composite system 700 includes a dressing layer 702, a backing layer 704 and a pair of opposed delivery layers 706. Each delivery layer 706 includes a tab 708 along an edge thereof that protrudes beyond the extents of dressing layer 702. As provided tabs 708 may be folded inwardly as depicted in FIG. 11B. In use, each tab 708 may be folded out to provide a non-adhesive gripping surface that may be handled to place the dressing layer 702 over the wound. Tabs 708 may eliminate a need for gripping an adhesive coating on dressing layer 702, and thereby improve the sealing characteristics of the dressing layer 702 and promote the cleanliness of the wound “w.”


Referring now to FIG. 12A through FIG. 12C, another embodiment of a composite dressing and delivery apparatus is depicted generally as 800. Composite system 800 includes a dressing layer 802, a backing layer 804 and a delivery layer 806. Dressing layer 802 is generally triangular in shape such that it may conform to contours of an irregular body part such as a heel “h” as depicted in FIG. 12A. Also, a dressing layer 802 configured with a triangular shape may offer a convenient form to include multiple peripheral regions 814 on backing layer 804, and multiple peripheral regions 830 on delivery layer 806. Multiple peripheral regions 814, 830 may facilitate placement of dressing layer 802 in the event that customizing or cutting the composite system 800 results in the removal of one or more of the peripheral regions 814, 830.


Although the foregoing disclosure has been described in some detail by way of illustration and example, for purposes of clarity or understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

Claims
  • 1. A wound therapy kit comprising: a wound dressing comprising a dressing layer configured for placement over a wound, and a backing layer adhered to the dressing layer in a releasable manner; anda patch configured to be secured to the dressing layer, the patch comprising: a patch layer configured to prevent leaks,a patch backing layer adhered to the patch layer, the patch backing layer configured to be removed from an underside of the patch layer,a patch delivery layer adhered to the patch layer, the patch delivery layer configured to be removed from a top surface of the patch layer,a first identifier disposed on any of the patch layer, the patch backing layer, or the patch delivery layer, anda second identifier disposed on any of the patch layer or the patch delivery layer.
  • 2. The therapy kit according to claim 1, further comprising at least one of a wound filler adapted for placement in the wound and a wound contact layer adapted for placement in contact with the wound.
  • 3. The therapy kit according to claim 1, further comprising a canister adapted to collect wound exudates.
  • 4. The therapy kit according to claim 1, wherein the dressing layer comprises a vacuum port.
  • 5. The therapy kit according to claim 4, further comprising a fluid conduit configured to be attached to the vacuum port.
  • 6. The therapy kit according to claim 4, wherein the patch layer comprises an opening configured to substantially surround the vacuum port.
  • 7. The therapy kit according to claim 1, wherein the patch layer is flexible.
  • 8. The therapy kit according to claim 1, wherein the patch layer is substantially round.
  • 9. The therapy kit according to claim 1, wherein the patch layer is substantially elongate.
  • 10. The therapy kit according to claim 1, wherein the patch backing layer configured to expose an adhesive coating on an underside of the patch layer when the patch backing layer is removed.
  • 11. A wound therapy kit comprising: a wound dressing comprising a dressing layer configured for placement over a wound, and a backing layer adhered to the dressing layer in a releasable manner; anda patch configured to be secured to the dressing layer, the patch comprising: a patch layer configured to prevent leaks,a patch backing layer adhered to the patch layer,a patch delivery layer adhered to the patch layer,a first identifier disposed on any of the patch layer, the patch backing layer, or the patch delivery layer, anda second identifier disposed on any of the patch layer or the patch delivery layer,wherein the first and second identifiers comprise indicia representative of an order of removal of the patch backing layer and the patch delivery layer from the patch layer.
  • 12. The therapy kit according to claim 11, further comprising at least one of a wound filler adapted for placement in the wound and a wound contact layer adapted for placement in contact with the wound.
  • 13. The therapy kit according to claim 11, further comprising a canister adapted to collect wound exudates.
  • 14. The therapy kit according to claim 11, wherein the patch layer is flexible.
  • 15. The therapy kit according to claim 11, wherein the patch layer is substantially round.
  • 16. The therapy kit according to claim 11, wherein the patch layer is substantially elongate.
  • 17. A wound therapy kit comprising: a wound dressing comprising a dressing layer configured for placement over a wound, and a backing layer adhered to the dressing layer in a releasable manner;a patch configured to be secured to the dressing layer, the patch comprising: a patch layer configured to prevent leaks,a patch backing layer adhered to the patch layer, anda patch delivery layer adhered to the patch layer;wherein the dressing layer comprises a vacuum port; andwherein the patch layer comprises an opening configured to substantially surround the vacuum port.
  • 18. The therapy kit according to claim 17, further comprising a fluid conduit configured to be attached to the vacuum port.
  • 19. The therapy kit according to claim 17, wherein the patch layer is substantially round.
  • 20. The therapy kit according to claim 17, wherein the patch layer is substantially elongate.
CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation application of and claims the benefit of priority under 35 U.S.C. §120 to co-pending U.S. patent application Ser. No. 12/176,773, filed Jul. 21, 2008, titled THIN FILM WOUND DRESSING, the entirety of which is hereby incorporated by reference herein for all purposes.

US Referenced Citations (281)
Number Name Date Kind
3026874 Stevens Mar 1962 A
3367332 Groves Feb 1968 A
3486504 Austin, Jr. Dec 1969 A
3572340 Lloyd et al. Mar 1971 A
3712298 Snowdon et al. Jan 1973 A
3809086 Schachet et al. May 1974 A
3874387 Barbieri Apr 1975 A
3980166 DeFeudis Sep 1976 A
4063556 Thomas et al. Dec 1977 A
4080970 Miller Mar 1978 A
4112947 Nehring Sep 1978 A
4112949 Rosenthal et al. Sep 1978 A
4136696 Nehring Jan 1979 A
4202331 Yale May 1980 A
4224945 Cohen Sep 1980 A
4228798 Deaton Oct 1980 A
4266545 Moss May 1981 A
4280680 Payne Jul 1981 A
4382441 Svedman May 1983 A
4499896 Heinecke Feb 1985 A
4510802 Peters Apr 1985 A
4524064 Nambu Jun 1985 A
4538645 Perach Sep 1985 A
4600001 Gilman Jul 1986 A
4655754 Richmond et al. Apr 1987 A
4700479 Saito et al. Oct 1987 A
4710165 McNeil et al. Dec 1987 A
4738257 Meyer et al. Apr 1988 A
4743232 Kruger May 1988 A
4786282 Wagle et al. Nov 1988 A
4870975 Cronk et al. Oct 1989 A
4874363 Abell Oct 1989 A
4917112 Kalt Apr 1990 A
4969880 Zamierowski Nov 1990 A
4984570 Langen et al. Jan 1991 A
4990137 Graham Feb 1991 A
4997438 Nipper Mar 1991 A
5000172 Ward Mar 1991 A
5059424 Cartmell et al. Oct 1991 A
5071409 Rosenberg Dec 1991 A
5100395 Rosenberg Mar 1992 A
5100396 Zamierowski Mar 1992 A
5106629 Cartmell et al. Apr 1992 A
5135485 Cohen et al. Aug 1992 A
5141503 Sewell, Jr. Aug 1992 A
5149331 Ferdman et al. Sep 1992 A
5152757 Eriksson Oct 1992 A
5160322 Scheremet et al. Nov 1992 A
5176663 Svedman et al. Jan 1993 A
5178157 Fanlo Jan 1993 A
5180375 Feibus Jan 1993 A
5195977 Pollitt Mar 1993 A
5261893 Zamierowski Nov 1993 A
5263922 Sova et al. Nov 1993 A
5265605 Afflerbach Nov 1993 A
5415627 Rasmussen et al. May 1995 A
5423737 Cartmell et al. Jun 1995 A
5447492 Cartmell et al. Sep 1995 A
D364679 Heaton et al. Nov 1995 S
5484427 Gibbons Jan 1996 A
5489262 Cartmell et al. Feb 1996 A
5501661 Cartmell et al. Mar 1996 A
5520629 Heinecke et al. May 1996 A
5527293 Zamierowski Jun 1996 A
5536233 Khouri Jul 1996 A
5549584 Gross Aug 1996 A
5588958 Cunningham et al. Dec 1996 A
5605165 Sessions et al. Feb 1997 A
5624374 Von Iderstein Apr 1997 A
5636643 Argenta et al. Jun 1997 A
5645081 Argenta et al. Jul 1997 A
5678564 Lawrence et al. Oct 1997 A
5701917 Khouri Dec 1997 A
5704905 Jensen et al. Jan 1998 A
5713842 Kay Feb 1998 A
5733305 Fleischmann Mar 1998 A
5738642 Heinecke et al. Apr 1998 A
5749842 Cheong et al. May 1998 A
5779657 Daneshvar Jul 1998 A
5840049 Tumey et al. Nov 1998 A
5911222 Lawrence et al. Jun 1999 A
5931800 Rasmussen et al. Aug 1999 A
5944703 Dixon et al. Aug 1999 A
5960837 Cude Oct 1999 A
5973221 Collyer et al. Oct 1999 A
6010524 Fleischmann Jan 2000 A
6043406 Sessions et al. Mar 2000 A
6071267 Zamierowski Jun 2000 A
6093465 Gilchrist et al. Jul 2000 A
6117111 Fleischmann Sep 2000 A
6135116 Vogel et al. Oct 2000 A
D434150 Tumey et al. Nov 2000 S
6142982 Hunt et al. Nov 2000 A
6168800 Dobos et al. Jan 2001 B1
6174306 Fleischmann Jan 2001 B1
6203563 Fernandez Mar 2001 B1
6261276 Reitsma Jul 2001 B1
6325788 McKay Dec 2001 B1
6345623 Heaton et al. Feb 2002 B1
6348423 Griffiths et al. Feb 2002 B1
6395955 Roe et al. May 2002 B1
6398767 Fleischmann Jun 2002 B1
6406447 Thrash et al. Jun 2002 B1
6420622 Johnston et al. Jul 2002 B1
6458109 Henley et al. Oct 2002 B1
6488643 Tumey et al. Dec 2002 B1
6500112 Khouri Dec 2002 B1
D469175 Hall et al. Jan 2003 S
D469176 Hall et al. Jan 2003 S
6520982 Boynton et al. Feb 2003 B1
6547255 Donaway et al. Apr 2003 B1
6553998 Heaton et al. Apr 2003 B2
D475134 Randolph May 2003 S
6557704 Randolph May 2003 B1
D478659 Hall et al. Aug 2003 S
6607495 Skalak et al. Aug 2003 B1
6626891 Ohmstede Sep 2003 B2
6648862 Watson Nov 2003 B2
6685681 Lockwood et al. Feb 2004 B2
6695823 Lina et al. Feb 2004 B1
6695824 Howard et al. Feb 2004 B2
D488558 Hall Apr 2004 S
6752794 Lockwood et al. Jun 2004 B2
6755807 Risk, Jr. et al. Jun 2004 B2
6764462 Risk, Jr. et al. Jul 2004 B2
6767334 Randolph Jul 2004 B1
6800074 Henley et al. Oct 2004 B2
6814079 Heaton et al. Nov 2004 B2
6824533 Risk, Jr. et al. Nov 2004 B2
6855135 Lockwood et al. Feb 2005 B2
6855860 Ruszczak et al. Feb 2005 B2
6856821 Johnson Feb 2005 B2
6887228 McKay May 2005 B2
6887263 Bleam et al. May 2005 B2
6936037 Bubb et al. Aug 2005 B2
6942633 Odland Sep 2005 B2
6942634 Odland Sep 2005 B2
6951553 Bubb et al. Oct 2005 B2
6960181 Stevens Nov 2005 B2
6979324 Bybordi et al. Dec 2005 B2
6994702 Johnson Feb 2006 B1
7022113 Lockwood et al. Apr 2006 B2
7037254 O'Connor et al. May 2006 B2
7052167 Vanderschuit May 2006 B2
7070584 Johnson et al. Jul 2006 B2
7077832 Fleischmann Jul 2006 B2
7093600 Sorribes Aug 2006 B2
7108683 Zamierowski Sep 2006 B2
7117869 Heaton et al. Oct 2006 B2
7128719 Rosenberg Oct 2006 B2
7128735 Weston Oct 2006 B2
7144390 Hannigan et al. Dec 2006 B1
7169151 Lytinas Jan 2007 B1
7182758 McCraw Feb 2007 B2
7195624 Lockwood et al. Mar 2007 B2
7198046 Argenta et al. Apr 2007 B1
7214202 Vogel et al. May 2007 B1
7216651 Argenta et al. May 2007 B2
D544092 Lewis Jun 2007 S
7273054 Heaton et al. Sep 2007 B2
7276051 Henley et al. Oct 2007 B1
7279612 Heaton et al. Oct 2007 B1
7316672 Hunt et al. Jan 2008 B1
D565177 Locke et al. Mar 2008 S
7338482 Lockwood et al. Mar 2008 B2
7351250 Zamierowski Apr 2008 B2
7361184 Joshi Apr 2008 B2
7381211 Zamierowski Jun 2008 B2
7381859 Hunt et al. Jun 2008 B2
7396345 Knighton et al. Jul 2008 B2
7401413 Nelson Jul 2008 B1
7410495 Zamierowski Aug 2008 B2
7413570 Zamierowski Aug 2008 B2
7413571 Zamierowski Aug 2008 B2
7422576 Boynton et al. Sep 2008 B2
7534927 Lockwood et al. May 2009 B2
7723560 Lockwood et al. May 2010 B2
7888546 Marcoux et al. Feb 2011 B2
7981136 Weiser Jul 2011 B2
8021347 Vitaris et al. Sep 2011 B2
8257326 Vitaris Sep 2012 B2
8491548 Livne et al. Jul 2013 B2
20010020145 Satterfield Sep 2001 A1
20010031943 Urie Oct 2001 A1
20010043943 Coffey Nov 2001 A1
20020016577 Ohmstede Feb 2002 A1
20020108614 Schultz Aug 2002 A1
20020143286 Tumey Oct 2002 A1
20020151836 Burden Oct 2002 A1
20020161346 Lockwood et al. Oct 2002 A1
20020198504 Risk, Jr. et al. Dec 2002 A1
20030078532 Ruszczak et al. Apr 2003 A1
20030093041 Risk, Jr. et al. May 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030208149 Coffey Nov 2003 A1
20030212357 Pace Nov 2003 A1
20030212359 Butler Nov 2003 A1
20030219469 Johnson et al. Nov 2003 A1
20040006319 Lina et al. Jan 2004 A1
20040030304 Hunt et al. Feb 2004 A1
20040039415 Zamierowski Feb 2004 A1
20040064111 Lockwood et al. Apr 2004 A1
20040064132 Boehringer et al. Apr 2004 A1
20040073151 Weston Apr 2004 A1
20040093026 Weidenhagen et al. May 2004 A1
20040113309 Thompson, Jr. et al. Jun 2004 A1
20040122434 Argenta et al. Jun 2004 A1
20040167482 Watson Aug 2004 A1
20040193218 Butler Sep 2004 A1
20040241213 Bray Dec 2004 A1
20040243073 Lockwood et al. Dec 2004 A1
20040249353 Risks, Jr. et al. Dec 2004 A1
20040260230 Randolph Dec 2004 A1
20050004534 Lockwood et al. Jan 2005 A1
20050010153 Lockwood et al. Jan 2005 A1
20050020955 Sanders et al. Jan 2005 A1
20050070835 Joshi Mar 2005 A1
20050070858 Lockwood et al. Mar 2005 A1
20050085795 Lockwood et al. Apr 2005 A1
20050090787 Risk, Jr. et al. Apr 2005 A1
20050101940 Radl et al. May 2005 A1
20050107756 McCraw May 2005 A1
20050131327 Lockwood et al. Jun 2005 A1
20050137539 Biggie et al. Jun 2005 A1
20050147562 Hunter et al. Jul 2005 A1
20050177190 Zamierowski Aug 2005 A1
20050182445 Zamierowski Aug 2005 A1
20050222527 Miller et al. Oct 2005 A1
20050222544 Weston Oct 2005 A1
20050261642 Weston Nov 2005 A1
20050261643 Bybordi et al. Nov 2005 A1
20050288691 Leiboff Dec 2005 A1
20060015087 Risk, Jr. et al. Jan 2006 A1
20060025727 Boehringer et al. Feb 2006 A1
20060029650 Coffey Feb 2006 A1
20060039742 Cable, Jr. et al. Feb 2006 A1
20060041247 Petrosenko et al. Feb 2006 A1
20060079852 Bubb et al. Apr 2006 A1
20060100586 Karpowicz et al. May 2006 A1
20060100594 Adams et al. May 2006 A1
20060116620 Oyaski Jun 2006 A1
20060149170 Boynton et al. Jul 2006 A1
20070005028 Risk, Jr. et al. Jan 2007 A1
20070014837 Johnson et al. Jan 2007 A1
20070016152 Karpowicz Jan 2007 A1
20070021697 Ginther Jan 2007 A1
20070027414 Hoffman et al. Feb 2007 A1
20070032754 Walsh Feb 2007 A1
20070032755 Walsh Feb 2007 A1
20070032778 Heaton et al. Feb 2007 A1
20070055209 Patel et al. Mar 2007 A1
20070066946 Haggstrom et al. Mar 2007 A1
20070078366 Haggstrom et al. Apr 2007 A1
20070078432 Halseth et al. Apr 2007 A1
20070167926 Blott et al. Jul 2007 A1
20070167927 Hunt et al. Jul 2007 A1
20070179460 Adahan Aug 2007 A1
20070185426 Ambrosio et al. Aug 2007 A1
20070219513 Lina et al. Sep 2007 A1
20070225663 Watt et al. Sep 2007 A1
20070233022 Henley et al. Oct 2007 A1
20080011667 Ruschke Jan 2008 A1
20080051688 Lowe Feb 2008 A1
20080071235 Locke et al. Mar 2008 A1
20080082059 Fink et al. Apr 2008 A1
20080103462 Wenzel et al. May 2008 A1
20080132819 Radl et al. Jun 2008 A1
20080167593 Fleischmann Jul 2008 A1
20080183233 Koch et al. Jul 2008 A1
20080200857 Lawhorn Aug 2008 A1
20080200906 Sanders et al. Aug 2008 A1
20080208147 Argenta et al. Aug 2008 A1
20080234641 Locke et al. Sep 2008 A1
20090227969 Jaeb et al. Sep 2009 A1
20090234313 Mullejeans et al. Sep 2009 A1
20090264805 Davis et al. Oct 2009 A1
20100010458 Sherman Jan 2010 A1
20100028390 Cleary et al. Feb 2010 A1
20100106106 Heaton et al. Apr 2010 A1
20120253255 Tsuruta et al. Oct 2012 A1
20140163486 Riesinger Jun 2014 A1
Foreign Referenced Citations (45)
Number Date Country
41 11 122 Apr 1993 DE
43 06 478 Sep 1994 DE
295 04 378 Oct 1995 DE
0 358 302 Mar 1990 EP
1 0588 569 Apr 2001 EP
1 219 311 Jul 2002 EP
0 853 950 Oct 2002 EP
488 232 Jul 1938 GB
1 415 096 Nov 1975 GB
1 549 756 Mar 1977 GB
2 195 255 Apr 1988 GB
2 235 877 Mar 1991 GB
2 307 180 May 1997 GB
2 329 127 Mar 1999 GB
2 336 546 Oct 1999 GB
2 344 531 Jun 2000 GB
2 415 908 Jan 2006 GB
1 762 940 Jan 1989 SU
WO 8001139 Jun 1980 WO
WO 8002182 Oct 1980 WO
WO 8401904 May 1984 WO
WO 8905133 Jun 1989 WO
WO 9011795 Oct 1990 WO
WO 9219313 Nov 1992 WO
WO 9309727 May 1993 WO
WO 9420041 Sep 1994 WO
WO 9605873 Feb 1996 WO
WO 0021586 Apr 2000 WO
WO 03005943 Jan 2003 WO
WO 03018098 Mar 2003 WO
WO 03030966 Apr 2003 WO
WO 03057070 Jul 2003 WO
WO 03057071 Jul 2003 WO
WO 03057307 Jul 2003 WO
WO 03045492 Aug 2003 WO
WO 03086232 Oct 2003 WO
WO 03092620 Nov 2003 WO
WO 03101508 Dec 2003 WO
WO 2004018020 Mar 2004 WO
WO 2005009488 Feb 2005 WO
WO 2006015599 Feb 2006 WO
WO 2006105892 Oct 2006 WO
WO 2008020862 Feb 2008 WO
WO 2008048481 Apr 2008 WO
WO 2009126103 Oct 2009 WO
Non-Patent Literature Citations (26)
Entry
US 6,216,701, 04/2001, Heaton et al. (withdrawn)
US 7,186,244, 03/2007, Hunt et al. (withdrawn)
KCI, Inc., V.A.C. Therapy Clinical Guidelines, A reference source for clinicians, Jul. 2007, in 92 pages.
KCI, Inc., V.A.C. Abdominal Dressing System, Advanced Management of the Open Abdomen, 2006, in 6 pages.
Björn, et al., “Irrigation Treatment in Split-thickness Skin Grafting of Intractable Leg Ulcers,” Scand J Plast Reconstr Surg 19:211-213, 1985.
B.M. Kostiuchenok, et al., “The Vacuum Effect in the Surgical Treatment of Purulen Wounds,” Russian Journal: Vestnik Khirurgii, Sep. 1986, (18-21).
Chardack, et al., “Experimental studies on Synthetic Substitutes for Skin and Their Use in the Treatment of Burns,” Annals of Surgery, vol. 155, No. 1, (127-139), 1962.
Chariker, M. E., et al. (eds). “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage,” Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63.
H. Teder, et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, vol. 3, (399-407), (1990).
Jeter, Katherine F., et al., “Managing Draining Wounds and Fistulae: New and Established Methods”, Chronic Wound Care, 1990, pp. 204-246.
Mulder, G.D., et al., “Clinicians' Pocket Guide to Chronic Wound Repair,” Wound Healing Publications Second Edition, 1991.
P. Svedman, “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation,” Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986 (125-133).
Paul Svedman, “A Dressing Allowing Continuous Treatment of a Biosurface,” IRCS Medical Science: Biomedical Technoloyg; Clinical Medicine; Surgery and Transplantation, 7, 221 (1979).
Paul Svedman, “Irrigation Treatment of Leg Ulcers,” Teh Lancet, Sep. 3, 1983 (532-534).
Paul Svedman, et al., “Staphylococcal Wound Infection in the Pig: Part 1. Course,” Annals of Plastic Surgery, vol. 23, No. 3, Sep. 1989 (212-218).
Ryosuke Fujimoro, M.D., et al., “Sponge Method for Treatment of Early Scars,” From the Department of Dermatology in the Faculty Medicine, Kyoto Univeristy, vol. 42, No. 4, Oct. 1968 (323-326).
Sandén, M.D., et al., “Staphylococcal Wound Infection in the Pig: Part II. Innoculation, Quantification of Bacteria, and Reproducibility,” Annals of Plastic Surgery, vol. 23, No. 3, Sep. 1989 (219-223).
Sherry Stoll, “Energetic Remedies—Cupping: Healing Within a Vacuum,” https://www.suite101.com/article.cfm/energetic) remedies/74531, Apr. 13, 2005.
W. Fleischmann, “Vacuum Sealing for Treatment of Problematical Wounds”, Univeristy Surgical Clinic and Polyclinic—Accident Surgery Department, WundForum Spezial—IHW 94, 4 pages, (1994).
W. Fleischman, et al., Vacuum Sealing: Indication, Technique and Results, Emr J Orthop Surg Tramatol (1995) 5:37-40.
Y.N. Usupov, et al., “Active Wound Drainage,” Russian Journal: Vestnik Khirugii, Apr. 1987, (42-45).
Yu A. Davydov, et al., “Bacteriological and Cytological Assessment of Vacuum Therapy of Purulent Wounds”, Vestnik Khirurgii, Oct. 1998, (48-52).
Yu A. Davydov, et al., “Concepts for Clinical Biological Management of the Wound Process in the Treatment of Purulent Wounds Using Vacuum Therapy,” Vestnik Khirugii, Feb. 1991, 132-135).
Yu A. Davydov, et al., “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis,” Russian Journal: Vesnik Khiturgii, Sep. 1986, (66-70).
Yu A. Davydov, et al., “Vacuum Therapy in treatment of Acute Purulent Diseases of Soft Tissues and Purulent Wounds,” Vestnik Khirurgii, (Surgeon's Herald), MEDICINE Publishers, 1986.
Gorica Zivadinovic, et al., “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Conference Papers of the 5th Timok Medical Days, Majdanpek, 1986 (161-164).
Related Publications (1)
Number Date Country
20110313339 A1 Dec 2011 US
Continuations (1)
Number Date Country
Parent 12176773 Jul 2008 US
Child 13218689 US